Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy
- PMID: 23114757
- PMCID: PMC3535923
- DOI: 10.1128/AAC.01454-12
Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy
Abstract
Development of daptomycin (DAP) resistance in Enterococcus faecalis has recently been associated with mutations in genes encoding proteins with two main functions: (i) control of the cell envelope stress response to antibiotics and antimicrobial peptides (LiaFSR system) and (ii) cell membrane phospholipid metabolism (glycerophosphoryl diester phosphodiesterase and cardiolipin synthase [cls]). However, the genetic bases for DAP resistance in Enterococcus faecium are unclear. We performed whole-genome comparative analysis of a clinical strain pair, DAP-susceptible E. faecium S447 and its DAP-resistant derivative R446, which was recovered from a single patient during DAP therapy. By comparative whole-genome sequencing, DAP resistance in R446 was associated with changes in 8 genes. Two of these genes encoded proteins involved in phospholipid metabolism: (i) an R218Q substitution in Cls and (ii) an A292G reversion in a putative cyclopropane fatty acid synthase enzyme. The DAP-resistant derivative R446 also exhibited an S333L substitution in the putative histidine kinase YycG, a member of the YycFG system, which, similar to LiaFSR, has been involved in cell envelope homeostasis and DAP resistance in other Gram-positive cocci. Additional changes identified in E. faecium R446 (DAP resistant) included two putative proteins involved in transport (one for carbohydrate and one for sulfate) and three enzymes predicted to play a role in general metabolism. Exchange of the "susceptible" cls allele from S447 for the "resistant" one belonging to R446 did not affect DAP susceptibility. Our results suggest that, apart from the LiaFSR system, the essential YycFG system is likely to be an important mediator of DAP resistance in some E. faecium strains.
Figures

Similar articles
-
Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content.PLoS One. 2012;7(8):e43958. doi: 10.1371/journal.pone.0043958. Epub 2012 Aug 27. PLoS One. 2012. PMID: 22952824 Free PMC article.
-
Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs.Antimicrob Agents Chemother. 2014 Aug;58(8):4527-34. doi: 10.1128/AAC.02686-14. Epub 2014 May 27. Antimicrob Agents Chemother. 2014. PMID: 24867964 Free PMC article.
-
LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium.Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0106923. doi: 10.1128/aac.01069-23. Epub 2024 Jan 30. Antimicrob Agents Chemother. 2024. PMID: 38289081 Free PMC article.
-
Mechanisms of drug resistance: daptomycin resistance.Ann N Y Acad Sci. 2015 Sep;1354:32-53. doi: 10.1111/nyas.12948. Epub 2015 Oct 23. Ann N Y Acad Sci. 2015. PMID: 26495887 Free PMC article. Review.
-
Antibiotic resistance in Enterococcus faecium clinical isolates.Expert Rev Anti Infect Ther. 2014 Feb;12(2):239-48. doi: 10.1586/14787210.2014.870886. Epub 2014 Jan 6. Expert Rev Anti Infect Ther. 2014. PMID: 24392717 Review.
Cited by
-
Emergence of a daptomycin-non-susceptible Enterococcus faecium strain that encodes mutations in DNA repair genes after high-dose daptomycin therapy.BMC Res Notes. 2016 Apr 1;9:197. doi: 10.1186/s13104-016-2003-9. BMC Res Notes. 2016. PMID: 27036708 Free PMC article.
-
Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).Sci Rep. 2020 Sep 30;10(1):16107. doi: 10.1038/s41598-020-73108-x. Sci Rep. 2020. PMID: 32999359 Free PMC article.
-
Whole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium Infection.Antimicrob Agents Chemother. 2016 Nov 21;60(12):7224-7235. doi: 10.1128/AAC.01649-16. Print 2016 Dec. Antimicrob Agents Chemother. 2016. PMID: 27671066 Free PMC article.
-
Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.Antimicrob Agents Chemother. 2016 Sep 23;60(10):5716-23. doi: 10.1128/AAC.00687-16. Print 2016 Oct. Antimicrob Agents Chemother. 2016. PMID: 27431211 Free PMC article.
-
Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background.Antimicrob Agents Chemother. 2015 Dec;59(12):7327-34. doi: 10.1128/AAC.01073-15. Epub 2015 Sep 14. Antimicrob Agents Chemother. 2015. PMID: 26369959 Free PMC article.
References
-
- Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, Segreti J. 2010. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: a retrospective, multicenter, cohort study. Clin. Ther. 32:1713–1719 - PubMed
-
- Twilla JD, Finch CK, Usery JB, Gelfand MS, Hudson JQ, Broyles JE. 2012. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin. J. Hosp. Med. 7:243–248 - PubMed
-
- Fraher MH, Corcoran GD, Creagh S, Feeney E. 2007. Daptomycin-resistant Enterococcus faecium in a patient with no prior exposure to daptomycin. J. Hosp. Infect. 65:376–378 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical